Dosage forms of sildenafil in the management of erectile dysfunction

Grigoryan V.A., Gazimiev M.A., Demidko Y.L., Baiduvaliev A.M.

Urologiia (Moscow, Russia : 1999)

№ 1, С. 159-162

Опубликовано: ## 2018

Тип ресурса: Статья

Аннотация:

The experience in the management of erectile dysfunction shows that taking even the most effective medications in tablet form may be inconvenient due to the need for natural settings for intimacy. The phosphodiesterase type 5 inhibitor sildenafil, presented in the orally disintegrating film formulation (Dynamic Forward), differs from all forms of the drug for the treatment of erectile dysfunction available in the Russian pharmaceutical market. The drug in the form of a film makes it possible to realize a pathogenetic approach to treating ED without changing the patients habitual way of life.

Рубрики Mesh:

Введение лекарств пероральное

Эректильная дисфункция - лекарственная терапия

Человек

Мужской

Фосфодиэстеразы 5 ингибиторы - кровь

Фосфодиэстеразы 5 ингибиторы - прием и дозировка

Фосфодиэстеразы 5 ингибиторы - терапевтическое применение

Силденафила цитрат - кровь

Силденафила цитрат - прием и дозировка

Силденафила цитрат - терапевтическое применение

Таблетки - прием и дозировка

Таблетки - фармакокинетика

Лекция

Язык текста: Русский

ISSN: 1728-2985

Grigoryan V.A.

Gazimiev M.A.

Demidko Y.L. Yu L

Baiduvaliev A.M.

Clinic of Urology, M. Sechenov First MSMU of Minzdrav of Russia, Moscow, Russia.

Dosage forms of sildenafil in the management of erectile dysfunction

Текст визуальный электронный

Urologiia (Moscow, Russia : 1999)

№ 1 С. 159-162

2018

erectile dysfunction

phosphodiesterase type 5 inhibitors

sildenafil

Статья

Administration, Oral E02.319.267.100

Введение лекарств пероральное E02.319.267.100

Erectile Dysfunction drug therapy C12.100.500.214 C12.100.875.486 C12.200.294.214 F03.835.400

Эректильная дисфункция лекарственная терапия C12.100.500.214 C12.100.875.486 C12.200.294.214 F03.835.400

Humans B01.050.150.900.649.313.988.400.112.400.400

Человек B01.050.150.900.649.313.988.400.112.400.400

Male

Мужской

Phosphodiesterase 5 Inhibitors blood D27.505.519.389.735.500

Phosphodiesterase 5 Inhibitors administration & dosage D27.505.519.389.735.500

Phosphodiesterase 5 Inhibitors therapeutic use D27.505.519.389.735.500

Фосфодиэстеразы 5 ингибиторы кровь D27.505.519.389.735.500

Фосфодиэстеразы 5 ингибиторы прием и дозировка D27.505.519.389.735.500

Фосфодиэстеразы 5 ингибиторы терапевтическое применение D27.505.519.389.735.500

Sildenafil Citrate blood D02.065.884.675 D02.886.590.700.675 D03.383.606.854 D03.633.100.759.824

Sildenafil Citrate administration & dosage D02.065.884.675 D02.886.590.700.675 D03.383.606.854 D03.633.100.759.824

Sildenafil Citrate therapeutic use D02.065.884.675 D02.886.590.700.675 D03.383.606.854 D03.633.100.759.824

Силденафила цитрат кровь D02.065.884.675 D02.886.590.700.675 D03.383.606.854 D03.633.100.759.824

Силденафила цитрат прием и дозировка D02.065.884.675 D02.886.590.700.675 D03.383.606.854 D03.633.100.759.824

Силденафила цитрат терапевтическое применение D02.065.884.675 D02.886.590.700.675 D03.383.606.854 D03.633.100.759.824

Tablets administration & dosage D26.255.830

Tablets pharmacokinetics D26.255.830

Таблетки прием и дозировка D26.255.830

Таблетки фармакокинетика D26.255.830

Lecture V02.533

Лекция V02.533

The experience in the management of erectile dysfunction shows that taking even the most effective medications in tablet form may be inconvenient due to the need for natural settings for intimacy. The phosphodiesterase type 5 inhibitor sildenafil, presented in the orally disintegrating film formulation (Dynamic Forward), differs from all forms of the drug for the treatment of erectile dysfunction available in the Russian pharmaceutical market. The drug in the form of a film makes it possible to realize a pathogenetic approach to treating ED without changing the patients habitual way of life.